Abstract:<h3 class="Heading">Background</h3><p class="Para">Stem cell-based bone tissue engineering shows promise for bone repair but faces some challenges, such as insufficient osteogenesis and limited architecture flexibility of the cell-delivery scaffold.</p><h3 class="Heading">Methods</h3><p class="Para">In this study, we first used lentiviral constructs to transduce ex vivo human bone marrow-derived stem cells with human bone morphogenetic protein-2 (<em class="EmphasisTypeItalic">BMP-2</em>) gene (<em class="EmphasisTypeItalic">BMP</em>-hBMSCs). We then introduced these cells into a hydrogel scaffold using an advanced visible light-based projection stereolithography (VL-PSL) technology, which is compatible with concomitant cell encapsulation and amenable to computer-aided architectural design, to fabricate scaffolds fitting local physical and structural variations in different bones and defects.</p><h3 class="Heading">Results</h3><p class="Para">The results showed that the <em class="EmphasisTypeItalic">BMP</em>-hBMSCs encapsulated within the scaffolds had high viability with sustained <em class="EmphasisTypeItalic">BMP-2</em> gene expression and differentiated toward an osteogenic lineage without the supplement of additional BMP-2 protein. In vivo bone formation efficacy was further assessed using an intramuscular implantation model in severe combined immunodeficiency (SCID) mice. Microcomputed tomography (micro-CT) imaging indicated rapid bone formation by the <em class="EmphasisTypeItalic">BMP</em>-hBMSC-laden constructs as early as 14 days post-implantation. Histological examination revealed a mature trabecular bone structure with considerable vascularization. Through tracking of the implanted cells, we also found that <em class="EmphasisTypeItalic">BMP</em>-hBMSC were directly involved in the new bone formation.</p><h3 class="Heading">Conclusions</h3><p class="Para">The robust, self-driven osteogenic capability and computer-designed architecture of the construct developed in this study should have potential applications for customized clinical repair of large bone defects or non-unions.</p>

Potentiated Osteoinductivity Via Cotransfection with BMP-2 and VEGF Genes in Microencapsulated C2C12 Cells.

Co-transfection with BMP2 and FGF2 Via Chitosan Nanoparticles Potentiates Osteogenesis in Human Adipose-Derived Stromal Cells in Vitro.

Implantation of microencapsulated transgenic cells secreting Hbmp2 in bone tissue engineering

Vascular Derived ECM Improves Therapeutic Index of BMP-2 and Drives Vascularized Bone Regeneration.

Observation of Viability and BMP-2 Secretion of Three Different Microcapsulated Adult Stem Cells Transfected with BMP-2 Gene

Biologic Effect and Immunoisolating Behavior of BMP-2 Gene-Transfected Bone Marrow-Derived Mesenchymal Stem Cells in APA Microcapsules

Synergistic Effects of Controlled-Released BMP-2 and VEGF from nHAC/PLGAs Scaffold on Osteogenesis

In Vitro Osteogenic Induction Of Bone Marrow Stromal Cells With Encapsulated Gene-Modified Bone Marrow Stromal Cells And In Vivo Implantation For Orbital Bone Repair

Enhanced Osteogenic Activity of Mesenchymal Stem Cells and Co-Modified BMP-2 and Bfgf Genes.

In vivo ectopic osteogenesis of mouse bone marrow stromal stem cells transfected with bone morphogenetic protein 2 and vascular endothelial growth factor 165 genes

Effects of BMP2 and VEGF165 on the Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells.

Ectopic Osteogenesis of Mouse Bone Marrow Stromal Cells Transfected with BMP 2/VEGF165 Genes in Vivo

Enhancement of Bone Formation by Genetically-Engineered Bone Marrow Stromal Cells Expressing BMP-2, VEGF and Angiopoietin-1.

Efficiently Engineered Cell Sheet Using A Complex of Polyethylenimine-Alginate Nanocomposites Plus Bone Morphogenetic Protein 2 Gene to Promote New Bone Formation

Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold

In vitro study Of BMP-2 gene transfected bone marrow derived mesenchymal stem cells in APA microcapsules

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.

Co-cultivation of Progenitor Cells Enhanced Osteogenic Gene Expression and Angiogenesis Potential in Vitro

Effective delivery of bone morphogenetic protein 2 gene using chitosan–polyethylenimine nanoparticle to promote bone formation

Bmp2 and Vegf Promote Angiogenesis but Retard Terminal Differentiation of Osteoblasts in Bone Regeneration by Up-Regulating Id1

In vivo and in vitro study of osteogenic potency of endothelin-1 on bone marrow-derived mesenchymal stem cells